Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival. Takano EA, Younes MM, Meehan K, Spalding L, et al. BMC Cancer 2023;23:459.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Takano EA, Younes MM, Meehan K, Spalding L, et al. Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival. BMC Cancer 2023;23:459.
PMID: 37208678